- August 12, 2021
Yale Cancer Center Perspective Highlights New Advances for NSCLC
- April 26, 2021
Yale Cancer Center’s Dr. Lieping Chen Elected to Prestigious National Academy of Sciences
- March 02, 2021Source: OneLive
Dr. Goldberg on the Toxicity Profile of Amivantamab in Metastatic EGFR Exon 20–Mutant NSCLC
- December 18, 2020
Yale Study Leads to FDA Approval of Drug to Treat Non-small Cell Lung Cancer
- October 07, 2020
Yale Cancer Center Researchers Report Results of Afatinib plus Cetuximab for Treatment of EGFR-Mutant NSCLC
Building a Powerhouse Team To Tackle Lung Cancer